Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Hemodynamic Stability in Pediatric Laparoscopic Appendectomy
NCT05238506Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Mar 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in acute appendicitis (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Hemodynamic reaction to tracheal intubation. Started Mar 2022; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT05238506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05238506.